AMPE OTC
Ampio Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +3421.2%
1Y: +6681.5%
3Y: -95.4%
5Y: -100.0%
$0.18
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$250K
+88.0% ▲
Operating Income
-$10M
+53.3% ▲
Net Income
-$9M
+47.2% ▲
EPS (Diluted)
$-10.66
+63.6% ▲
EBITDA
-$8M
+63.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $1M | $1M | $1M | $2M | $250K |
| Gross Profit | -$1M | -$1M | -$1M | -$2M | -$250K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $13M | $9M | $12M | $9M | $2M |
| SG&A Expenses | $6M | $7M | $9M | $11M | $7M |
| Operating Expenses | $17M | $16M | $19M | $18M | $9M |
| Operating Income | -$19M | -$16M | -$21M | -$20M | -$10M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $77K | $0 | $0 | $0 | $0 |
| Income Before Tax | -$14M | -$16M | -$17M | -$16M | -$9M |
| Tax Expense | -$5M | $604K | -$5M | -$8M | $0 |
| Net Income | -$14M | -$16M | -$17M | -$16M | -$9M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-18.32 | $-27.59 | $-18.59 | $-29.32 | $-10.66 |
| EBITDA | -$12M | -$15M | -$16M | -$23M | -$8M |
| Shares Outstanding | 474026 | 595407 | 683210 | 753619 | 810113 |